Thomas Rogers, MD, PhD

Results from a Scripps Research and UNC team pave the way for a vaccine and therapeutic antibodies that could be stockpiled to fight future coronavirus pandemics.

Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses.

Scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.

FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. 

Findings of the new study support many vaccine strategies currently being used to tackle the new coronavirus.

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against the coronavirus that causes the disease.

An international research network centers around ReFRAME, the world’s leading collection of drugs known to be safe in humans.